Iterum Therapeutics plc
ITRMDelisted Jun 23, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659323
Iterum Therapeutics plc was delisted on Jun 23, 2026; its insiders filed their last Form 4 on Nov 20, 2025; 18 institutions reported holding it in 13F filings for Q1 2026, worth $41.3K in total; no superinvestor held it.
Q3 2025 vs. Q2 2025
How the institutions holding Iterum Therapeutics plc changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 24 | 24 | 0 |
| Shares | 2.39M | 1.35M | −1.04M (−43.4%) |
| Value | $2.38M | $904.1K | −$1.47M (−62.0%) |
New holders (8)
Institutions that held Iterum Therapeutics plc at the end of Q3 2025 but not at the end of Q2 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gen-Wealth Partners Inc | 82,047 | $55.0K | 0.02% |
| Virtu Financial LLC | 47,131 | $32.0K | 0.00% |
| Krilogy Financial LLC | 40,000 | $24.6K | 0.00% |
| SG Americas Securities, LLC | 16,820 | $11.0K | 0.00% |
| Susquehanna International Group, LLP | 11,701 | $7.84K | 0.00% |
| Cypress Capital Management LLC (WY) | 66 | $44 | 0.00% |
| GGM Financials LLC | 1 | $1 | 0.00% |
| CWM, LLC | 66 | $0 | 0.00% |
Sold out (8)
Institutions that held Iterum Therapeutics plc at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| Sabby Management, LLC | 430,761 | $428.6K |
| New Leaf Venture Partners, L.L.C. | 345,020 | $343.3K |
| Creative Financial Designs Inc | 76,047 | $75.7K |
| Two Sigma Investments, LP | 25,245 | $25.1K |
| Raymond James Financial Inc | 4,513 | $4.49K |
| Newbridge Financial Services Group, Inc. | 15 | $15 |
| HM Payson & Co | 3 | $3 |
| Royal Bank of Canada | 5 | $0 |